You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Kelonia
since
auto-detected in 2 stories
4 days ago
Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in vivo CAR-T.
5 days ago
Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says ⊕
found
A deal could be reached as soon as Monday and could include additional payments tied to Kelonia meeting certain milestones, The Wall Street Journal reported.
page 1 of 1